Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue
- PMID: 20538612
- PMCID: PMC2924087
- DOI: 10.1074/jbc.M110.111104
Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue
Abstract
A missense C1858T single nucleotide polymorphism in the PTPN22 gene recently emerged as a major risk factor for human autoimmunity. PTPN22 encodes the lymphoid tyrosine phosphatase (LYP), which forms a complex with the kinase Csk and is a critical negative regulator of signaling through the T cell receptor. The C1858T single nucleotide polymorphism results in the LYP-R620W variation within the LYP-Csk interaction motif. LYP-W620 exhibits a greatly reduced interaction with Csk and is a gain-of-function inhibitor of signaling. Here we show that LYP constitutively interacts with its substrate Lck in a Csk-dependent manner. T cell receptor-induced phosphorylation of LYP by Lck on an inhibitory tyrosine residue releases tonic inhibition of signaling by LYP. The R620W variation disrupts the interaction between Lck and LYP, leading to reduced phosphorylation of LYP, which ultimately contributes to gain-of-function inhibition of T cell signaling.
Figures









Similar articles
-
Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.PLoS One. 2014 Feb 3;9(2):e86677. doi: 10.1371/journal.pone.0086677. eCollection 2014. PLoS One. 2014. PMID: 24498279 Free PMC article.
-
The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.PLoS One. 2013;8(1):e54569. doi: 10.1371/journal.pone.0054569. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23359562 Free PMC article.
-
The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.Autoimmun Rev. 2013 May;12(7):717-25. doi: 10.1016/j.autrev.2012.12.003. Epub 2012 Dec 20. Autoimmun Rev. 2013. PMID: 23261816 Review.
-
LYP inhibits T-cell activation when dissociated from CSK.Nat Chem Biol. 2012 Mar 18;8(5):437-46. doi: 10.1038/nchembio.916. Nat Chem Biol. 2012. PMID: 22426112 Free PMC article.
-
Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.Curr Drug Targets. 2014 Mar;15(3):335-46. doi: 10.2174/13894501113146660236. Curr Drug Targets. 2014. PMID: 24188455 Review.
Cited by
-
PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy.Expert Opin Drug Discov. 2022 Aug;17(8):825-837. doi: 10.1080/17460441.2022.2084607. Epub 2022 Jun 7. Expert Opin Drug Discov. 2022. PMID: 35637605 Free PMC article. Review.
-
Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.Annu Rev Immunol. 2014;32:83-119. doi: 10.1146/annurev-immunol-032713-120249. Epub 2013 Dec 18. Annu Rev Immunol. 2014. PMID: 24364806 Free PMC article. Review.
-
The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.Clin Exp Immunol. 2014 Oct;178(1):178-89. doi: 10.1111/cei.12393. Clin Exp Immunol. 2014. PMID: 24905474 Free PMC article.
-
The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.Hum Immunol. 2013 May;74(5):574-85. doi: 10.1016/j.humimm.2012.12.017. Epub 2013 Jan 17. Hum Immunol. 2013. PMID: 23333624 Free PMC article.
-
Whole-Exome Sequencing: Discovering Genetic Causes of Granulomatous Mastitis.Int J Mol Sci. 2025 Jan 6;26(1):425. doi: 10.3390/ijms26010425. Int J Mol Sci. 2025. PMID: 39796280 Free PMC article.
References
-
- Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G. F., Lucarelli P., Pellecchia M., Eisenbarth G. S., Comings D., Mustelin T. (2004) Nat. Genet. 36, 337–338 - PubMed
-
- Begovich A. B., Carlton V. E., Honigberg L. A., Schrodi S. J., Chokkalingam A. P., Alexander H. C., Ardlie K. G., Huang Q., Smith A. M., Spoerke J. M., Conn M. T., Chang M., Chang S. Y., Saiki R. K., Catanese J. J., Leong D. U., Garcia V. E., McAllister L. B., Jeffery D. A., Lee A. T., Batliwalla F., Remmers E., Criswell L. A., Seldin M. F., Kastner D. L., Amos C. I., Sninsky J. J., Gregersen P. K. (2004) Am. J. Hum. Genet. 75, 330–337 - PMC - PubMed
-
- Bottini N., Vang T., Cucca F., Mustelin T. (2006) Semin. Immunol. 18, 207–213 - PubMed
-
- Gregersen P. K., Lee H. S., Batliwalla F., Begovich A. B. (2006) Semin. Immunol. 18, 214–223 - PubMed
-
- Todd J. A., Walker N. M., Cooper J. D., Smyth D. J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S. F., Payne F., Lowe C. E., Szeszko J. S., Hafler J. P., Zeitels L., Yang J. H., Vella A., Nutland S., Stevens H. E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L. J., Healy B., Burren O. S., Lam A. A., Ovington N. R., Allen J., Adlem E., Leung H. T., Wallace C., Howson J. M., Guja C., Ionescu-Tîrgovişte C., Simmonds M. J., Heward J. M., Gough S. C., Dunger D. B., Wicker L. S., Clayton D. G. (2007) Nat. Genet. 39, 857–864 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous